Masimo Corporation

Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. Masimo is committed to improving patient outcomes and reducing cost of care by working with dedicated hospital staff to convert healthcare institutions around the world to Masimo SET pulse oximetry technology. We are accomplishing this goal through partnering with our patient monitoring companies and caregivers and creating innovative, cost-effective acquisition programs for Masimo SET products for the benefit of the patients. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb™) monitoring technology. The recent introduction of the first-and-only FDA-cleared technology that noninvasively and continuously measures total hemoglobin without a painful needle stick and invasive blood draw is expected to open new markets and significantly expand the company’s growth opportunities. For more than 20 years now, Masimo has been focused on a singular mission — to create noninvasive patient monitoring technologies that are more effective and reliable and to improve patient outcomes and reduce the cost of care by bringing these technologies to new sites and applications. The result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making.

Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1989
Size (employees)
1,243 (est)
Website
masimo.com
Masimo Corporation was founded in 1989 and is headquartered in Irvine, US

Masimo Corporation Office Locations

Masimo Corporation has offices in Irvine, Washington, Cleveland, Singapore and in 29 other locations
Irvine, US (HQ)
52 Discovery
Show all (32)

Masimo Corporation Financials and Metrics

Masimo Corporation Financials

Masimo Corporation's revenue was reported to be $663.8 m in FY, 2016
USD

Revenue (Q2, 2017)

192.9 m

Gross profit (Q2, 2017)

128.4 m

Gross profit margin (Q2, 2017), %

67%

EBIT (Q2, 2017)

46.9 m

Market capitalization (11-Dec-2017)

4.8 b

Cash (07-Jan-2017)

331.4 m
Masimo Corporation's current market capitalization is $4.8 b.
USDFY, 2015FY, 2016

Revenue

630.1 m663.8 m

Revenue growth, %

7%5%

General and administrative expense

252.7 m241 m

Operating expense total

252.7 m241 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017

Revenue

131.4 m139.8 m140.9 m144.1 m152.6 m154.5 m167.6 m171.2 m172.6 m186.3 m192.9 m

Cost of goods sold

44 m47.5 m47.8 m47.9 m50.3 m51.4 m57.5 m57 m57.5 m62.2 m64.5 m

Gross profit

87.5 m92.3 m93.1 m96.2 m102.2 m103.1 m110.1 m114.2 m115.1 m124.1 m128.4 m

Gross profit Margin, %

67%66%66%67%67%67%66%67%67%67%67%
USDFY, 2015FY, 2016

Cash

132.3 m306 m

Inventories

62 m72.5 m

Current Assets

299.1 m507.2 m

PP&E

132.5 m136 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q2, 2017

Cash

91.7 m117.5 m97.1 m119 m103.6 m135.7 m119.4 m126 m139.9 m116.1 m343.8 m331.4 m

Inventories

59.5 m55.5 m58.3 m62.8 m73.3 m69.6 m71.6 m67 m62.5 m62.3 m80.3 m88.5 m

Current Assets

261.9 m286.7 m272 m299.6 m297.5 m315.5 m309.6 m324.6 m317.5 m296 m556.3 m566 m

PP&E

24.9 m25.5 m82.4 m87.6 m128.6 m108.7 m122.7 m133.2 m133.3 m133 m136.2 m137.7 m
USDFY, 2015FY, 2016

Net Income

81.5 m300.7 m

Depreciation and Amortization

15.7 m16.8 m

Accounts Receivable

(9.9 m)(21.2 m)

Accounts Payable

(4.3 m)7.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017

Net Income

15.5 m22.5 m14 m16.1 m19.8 m

Inventories

58.3 m62.8 m73.3 m69.6 m71.6 m67 m62.5 m62.3 m80.3 m

Accounts Payable

29.1 m29 m28.7 m27.1 m32.5 m32.2 m25.3 m30.7 m35 m
USDY, 2017

Revenue/Employee

155.2 k

Financial Leverage

1.3 x
Show all financial metrics

Masimo Corporation Operating Metrics

FY, 2016

Patents Issued

598

Patents Pending

315
Show all operating metrics

Masimo Corporation Market Value History

Masimo Corporation Revenue Breakdown

Masimo Corporation Median Salaries

Source: 56 public H-1B filings from Masimo Corporation

Masimo Corporation's Web-traffic and Trends

Masimo Corporation Online and Social Media Presence

Masimo Corporation Company Life and Culture

You may also be interested in